Status:

COMPLETED

A Long Term Extension Study of E2080 in Lennox-Gastaut Patients

Lead Sponsor:

Eisai Co., Ltd.

Conditions:

Lennox-Gastaut Syndrome

Eligibility:

All Genders

4-30 years

Phase:

PHASE3

Brief Summary

To investigate the safety of long term administration of E2080 in the patients with Lennox-Gastaut syndrome who completed the E2080-J081-304 Study.

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Participants who have completed the evaluation of Week 12 of the E2080-J081-304 study.
  • Male participants with reproductive ability and female participants with child-bearing potential, or their partners, had to be able to take medically appropriate contraceptive measures.
  • Participants who have provided a written informed consent to participate in this clinical trial until the evaluation of week 12 of the E2080-J081-304 study.
  • Participants who had a family member or a caregiver capable of recording the reporting diary, providing participant information necessary for the study, assisting treatment compliance, and accompanying the participant on scheduled visit days during the study period.
  • Exclusion criteria:
  • Participants who were judged by the investigator that they are unfit to participate in this clinical study for safety reasons based on the information up to the evaluation of week 12 of the E2080-J081-304 Study.
  • Participants who were judged by the investigator that they are likely to become non-compliant with administration during the clinical trial period.
  • Participants who were judged by the investigator that they were unfit to participate in this clinical trial.

Exclusion

    Key Trial Info

    Start Date :

    November 1 2010

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    August 1 2013

    Estimated Enrollment :

    54 Patients enrolled

    Trial Details

    Trial ID

    NCT01151540

    Start Date

    November 1 2010

    End Date

    August 1 2013

    Last Update

    March 11 2019

    Active Locations (23)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 6 (23 locations)

    1

    Nagoya, Aichi-ken, Japan

    2

    Matsuyama, Ehime, Japan

    3

    Fukuoka, Fukuoka, Japan

    4

    Hiroshima, Hiroshima, Japan